Enhanced Angiogenic Capability of Monocyte-Enriched Mononuclear Cell Suspensions from Patients with Systemic Scleroderma  by Marczak, Maria et al.
Enhanced Angiogenic Capability of 
Monocyte-Enriched Mononuclear Cell Suspensions 
from Patients with Systemic Scleroderma 
M a ria Marczak, V.D. , Slawomir Maj ewski , M .D ., Ewa Skopinska-Rozewska, M .D ., 
Igor Polakowski , M .Sc., and Stefani a Jablonska, M .D . 
Departm ent o r Derm ato logy (MM . SM. SJ) and Institu te of Ped iatrics, Division of Diag nostic Laboratory and C lin ica l 
Imm un o logy (ES- 1 ~). Warsaw Med ica l Academy. Warsaw; and Deparrntenr of Geron tology (IP), Postgraduate Warsaw School of 
Med icine, Warsaw, Poland 
D iffe rent subsets of peripheral bl ood m ono nuclea r cells 
(MN C) fro m 15 patients w ith sys temic scleroderm a were 
tes te d for th eir ab ility to evo ke ang iogenes is in a xenogenic 
sys t e m . The an giogenic capability o f to tal MNC from pa-
tients with sys temic scl eroderm a w as lower than th at of 
norm al human cell s, irrespective o f the fo rm o f the di sease. 
D iffercnt m echani sms have been pro posed fo r the pathogenesis o f sys temic scleros is (SSe), sugges tin g the in vo lve m ent of ab no rm al fi broblas t fun ctio n , a lte red immune reacti vit y, or changes in the mi-crovascul ar syste m as a p rim ary event in the d isease 
(fo r rev iew, sec I 1.2 1). . 
T h ere is so m e ev idence th at m o nocytcs play an Impo rtant ro le 
in t h e d eve lo pment o f ea rl y sta ges of the di sease 13,4]. It was also 
su gges ted t h ~ t chang es in conn ccti vL· ti ss ue cell s could be due to 
the acti o n o f pro du cts ge nerated by m onocy tcs w h1ch beco m e 
act iva ted durin g immune res po nse 15-7 1. 
In o ur prev io us wo rk we sho w ed the lowered ca pability o f 
peri phe ral b lood m o no nuclear cells (MN C) fro m patien ts w ith 
SSe to induce new blood-vessel fo rm atio n , Irrespecti ve of the 
fo rm of the d isease (8 ]. T his mig ht be relevant to the C:lp illa ry-
loss c ha racte ris ti c of SSe. H owever, it is no t kn own w hi ch MN C 
subsets arc res po nsible fo r this pheno m eno n. 
T h erefo re, th e aim of th e p resent stu dy was to tes t th e ang i-
ogenic ca pabili ty of 2 peripheral blood cell subpo pulati ? ns, i.e. , 
monocyte-enriched and m o nocy te-depleted, Iso lated tro m pa-
tien ts w ith SSe as compared w ith the capa bility of to tal MN C. 
For t his purpose we used a sensitive ly ntphocyte-induced angi-
ogen esis assay w hi ch permits s imultaneo us stud y of immuno-
competence of lymph o id cells and th eir effect on m icrovasculature 
[9 ]. 
PATIE NTS A ND M ETH O D S 
P atients Studi es were perfor m ed o n 15 pa ti ents w ith SSe (age 
range, 34-62; mean , 48. 6) and in 15 age- m atched health y ind i-
v id u a ls (age range, 20-48; m ea n , 40 .4) . T he g ro u p of pati ents 
incl u ded 4 indi vid uals w ith diffu se scleroderm a and 11 w ith ac-
Ma nuscript received Much 20, I <JHS; accepted fo r publi ca tion August 
22, I <J!lS. 
Supported in parr by a gran t from the Unircd Scleroderm a Foun da tion. 
and by a gran t fro m th e Polish Academy of Sciences (10.5) . 
Reprint req uests to: Slawo mi r Maj ewski . M.D .. Dc·partmcnr of Der-
mato logy. Warsaw Med ical Academy, 02-00H Wa rsaw, Koszy kowa H2 
A, Poland . 
A bbreviat iom: 
MNC: mononuclea r cdl (s) 
PI3S: phosplntc-b uiTercd sa line 
SSe: syste mi c scleroderma 
However, the ca pability of a mo nocyte-enriched subset of 
MN C fro m patients with scleroderma was found to be 
in creased , as compared w ith their to tal MNC and w ith that 
of the corresponding subset fro m healthy individuals. This 
mig ht be due to the activati on o fm onocytes in the disease. 
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rosckro derm a. The patients w ere eva luated accord ing to a stan-
da rd clini ca l and bbo rato ry p ro tocol (fo r cl ini ca l da ta, sec Table 
I). 
D iffuse scle roderm a was class ified acco rd in g to th e preliminary 
A RA criteria of M asi et al [ 12]. T he pa ti en ts we re classifi ed as 
hav in g diffuse sclerod erm a if ind u ra tio ns of the skin involved the 
face, extremities, and trunk (" proxim al cu ta neous in volve m ent") . 
w ith symmet ri c hyper- and depig m entations. T he co urse was 
usuall y rapid a1id severe, w ith a sho rt period between the o nset 
o f Ra ynaud 's pheno m eno n and the o nse t of indurat io ns. 
The criter ia fo r d iagnos ing patients as havin g acrosclcro der m :t 
and/or REST syndro m e were: ( I) pro no un ced Rayn:t ud 's phe-
no m enon , preceding ind u ra tio ns, and visceral in vo lve m ent of 
several yea rs' d uratio n ; (2) limi ted sk in changes con fi ned to the 
hands and face, w ith telangiectases and, in a p ro po rti o n o f cases, 
ca lcium depos its; and (3) pro tracted and rela ti vely benig n co urse 
I Io, 13 1. 
In lo ng-las tin g cases of acroscl cro dcrm a (cases 6, 7, 8 , 14) the 
cutaneous lesions beca m e w ides pread , altho ugh still m ore atrophic 
th an indurati ve, w ith so m e prox imal in vo lve ment, but w itho ut 
hyper- and dcpig m en ta tio ns. In these cases, after seve ral yea rs of 
slow progression , the course w as seve re. 
C ritni a of o rga n in vo lve m ent wne as fo ll ows: !tiii_I!S, chan ges 
on chest roentgenog rams and abno rm al pulmonary fun cti on tests; 
lr carr, cl1angcs o n ECG and /o r echoca rdiograph y; kidneys , ab-
no rm al clearance and /o r changes in urinalyses; mttsclc, prim ary 
muscle involvem ent on electro m yography, increased level of muscle 
enzy m es, changes in muscle bio psy . 
A minu clca r ami bod ies were m eas ured b y indi rect i mm un oflu-
o rescencc test I 14] w ith th e usc of diffe ren t substrates: rat li ver. 
m o nk ey esop hagus and, fo r centro m ere an tibod y determin ati o n , 
H Ep-2 cells li S]. 
Cell-medi ated immunity was m easured by in vitro and in vivo 
tes ts (E-rosette fo rm atio n , lymphocyte blas t transfo rm ati on , and 
qu antitat ive dinitrochlo ro ben zene tes t) fS.]. 
N o pat ients received systemi c therapy fo r 2 w eeks befo re the 
stud y o r d urin g th e stu dy. 
Preparation of Monocyte-Enriched and Monocyte-
Depleted MNC Subsets M o no nuclea r cells were isolated from 
peri phera l blood sa mples of hea lth y vo lunteers o r patients with 
SSe usin g Fico ll-Uro po line g rad ien t accordi ng to Boyum I 16] 
w ith s lig ht m odi fica ti o ns I 17]. T he interface MN C were com-
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Table I. C lini ca l and Labo ratory Da ta of Patients w ith Systemic Scleroderma 
Duration (yr) O rgan Involvement 
Patient Raynaud 's Cutaneo us Proximal ANA 
Sex/ Age Phenomenon C hanges' Arthralgia C utaneous Calcinosis Esophagus Lun gs Hea rt Kidney Muscles Capillaroscopy" Titer C M!b 
Diffuse Scleroderm a 
I . TF M/58 3 3 + + + + + + H < S 320 N q 
2. C M F/58 6 3 + + + + + + R < S 80 N /t 
3. TG F/37 2 0.5 + + + + + H < S 80 N q 
4. l' D F/36 3 2 + + + + + I{ = s 80 N /t 
Acrosclcrodernl3 
5. KE F/48 7 4 + + H > S () N 
6. LG F/60 8 7 + + + N () N 
7. T L F/62 29 28 + + + + + + + I{ = s 40 N n 
8. 0 1-1 F/47 12 9 + + + + H > S 40 N 
9. JM F/34 3 1 + + + + R < S 640 N /L 
10. Sl F/48 13 13 + + + + + R < S 80 N 
II. KA F/37 0.5 0.5 + + H 0 N 
12. GC F/42 16 7 + + + + + R > S 40" N 
13. ZJ F/47 3 I + + + R > S 320 N 
14. J A M/6 1 19 18 + + + + H < S 40 
15. WJ M/54 .I 0.5 + + N I c,o,~ N 
·•rt = G ig:mti c. uneven loops w ith enlarged cen tral po rtion, char:ICLcriscic o f R:tynaud 's phenomenon; S = loss o f capillaries . characte ris ti c of sys tnni c scle roderm a 1 t 0. 1 IJ . 
' L = Decrease , N = no rmal; CMI (cell- med iated immunity) wa s considered as decreased if2 in vit ro tes ts (E rosettes and lympho cyte transfo rm atio n) and /o r sensitization 
to DN CI3 test were ab norm al JSJ. 
; In diffuse scl erOd erma the lesions were w ides pread o r gcncr:ilizcd, indurati ve, often w ith hyper- and dcpigm cntatio ns. In acrosclc rodc rm a induratio ns were sli g h r and 
lim ited to the fi ngers and /o r hands w ith o ut scle roderma g rip . 
.tA nt icentro mcn: anti bodies. 
pri sed of 85-95% ly mphocy tes and 5-15% m o nocytes as de fin ed 
by morph o logy of Giem sa- stained preparations and pero x idase 
sta inin g. T he po lymo rph o nu clear co ntaminatio n was always less 
than 2''l'o. M o nocy te-enri ched fracti o n s were prepared accordin g 
to H aegert 118] with sli ght m odifi catio n, by in cubatio n of MN C 
suspensio ns o n plastic Petri dishes fo r 60 min at 3rC in TC 199 
medium supple m ented w ith 10%, hum an AB serum , follow ed by 
washin g to rem ove no nadheren t lympho id cells. After subseq uent 
incubatio n for 2 h w ith salin e at 4°C, the monocy te-enriched 
fra ctio ns were harves ted with a rubber po lice m an . 
T he no nad heren t cell s w ere fo und to consist of abou t 95% 
lymphocytes and 5% m o nocytes as defi ned by th e criteria de-
scribed above. The adherent fractio ns consisted o f m o re th an 75% 
monocytes. The viability of nonadherent and adherent cell s was 
hi gher than 90 and 75%, respecti vely , as detected by the t r ypan 
b lue ex clusio n test . T he cell s to be tested were washed t w ice an d 
resuspended to the des ired concentrati on (107 o f v iable cell s p er 
1 ml ofTC 199 m edium ) . 
Angiogenesis Assay W e used the ang io genesis assay described 
by Sidk y and Auerbach [9] which is a suitabl e model fo r tes tin g 
both immunocompetence and the ang io geni c ca pabi lity of lym-
ph o id cell s in the xenogeni c sys tem [8, 171. In brief, MN C recip-
ients we re immunosuppressed by a tota l-body x- ray ex posure of 
600 R (Mi:ill er RT 100 x-ray apparatus, 100 R / min in ::~ ir , filter 
Table II. Ang iogeni c C apability of Periphera l B lood MN C Subsets from Patients w ith SSe 
Patients 
Diffu se Sclcrodnma 
1. TF 
2. C M 
3. TG 
4. PD 
Acrosclcroderma 
5. KE 
6. LG 
7. TL 
8. 0 1-1 
9. JM 
10. Sl 
II . Kf\ 
12. GC 
13. ZJ 
14. JA 
15. WJ 
SSe (mean) 
Control (mean) 
Total MN C 
15.3 
11.7 
11.7 
10. 1 
10.6 
16.4 
12.5 
10.9 
11 .4 
11. 7 
11.7 
8.9 
11.7 
12.2 
11.3 
11 .87 ± 0.49( 15) 
14.05 ± 0.18 (15) 
Angiogenic Ca pabi lity 
Monocyte- Depleted Monocyte-Enriched 
19. 2 20.5 
14. 1 18. 7 
11 .4 n.d . 
14.0 n.d. 
13. 2 n.d. 
12.5 21.1 
18.7 17.9 
14.H 15.6 
15. 1 17.2 
14. 1 17.4 
12.0 17.9 
12.9 13.3 
13.3 13.7 
n.d. n.d . 
8 9 14.0 
13.87 ± 0.71 (14) 17.03 ± 0.79 (11 ) 
15.4 1 ± 0.84( 12) 14. 86 ± 0.55 (9) 
. A ngioge l ~i c G'p.ab ilit ~ is cx p~~ssc.:d as the m ean lllllll ber of nl'w ly for m ed b lood vcssd s per s ing le injection site. Number or in d iv idu als is g iven in parent heses. The-
differences 111 :m g;mgcmc capab d1 ty between SSe and COilt ro l to tal MN C arc sig;niti c:mt (J' < (1.05): between mo nocyte-enriched subsets (p < 0.05); between m o nocyte-
depleted and m o nocy te-e nriched subsl.'ts in patients w ith SSe at p < (1.05: and bcrwccn to tal MN C and m o nocy te-enri ched subse ts in p:ni cnts w ith SSe at p < 0.0 1 (cstim atl.~ 
by Wilco xon test). 
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AI 1 .25 mm, irradiation at 10 mA , 70 kV) 2 h befo re the cell 
inj e ctio n . T he recipients (8- to 10-week-o ld female B ALB/c inbred 
mice ) w e re anesthetized with chloral hydrate; both fl anks w ere 
sh a v ed and injected i.d. with 106 viable hum an cells in 0 .1 ml o f 
T C 199 m edium supplem ented w ith 0.01% t ry pan blue. Each 
recipient w as inj ected with at leas t 3 different inocu la, i.e., to tal 
MNC, m o nocyte- enri ched and monocyte-depleted subsets. In 
each exp eriment, J -5 mi ce were used, depending on yield o f th e 
ce lls. 
A f ter 3 d ays the mi ce were kil led , their skin w as separated fro m 
u nde rl y in g ti ss ues, and its inner surface was inspected und er the 
d issectin g mi crosco pe.: (magnifi ca ti o n x 20). All b lood vessels 
d irec ted towa rd the inj ection site we re counted acco rdin g to pre-
v io u s ly pro posed crite ri a [9]. These vesse ls differed fro m the 
back g ro und vasculature due to th eir to rtuos ity and bifurca tio ns. 
All countings were b lind . 
Detection ofT-Lymphocyte Antigenic Determinants on 
Total MNC and Nonadhereni: Cells T-Lymphocy te subsets 
wer e an a lyzed usin g Ortho clo ne reagents (OKT4 and O KT8) in 
a n indirect immuno flu o rescent s tainin g m eth od . Fluo rescein-con-
j u ga ted goa t antimo use lgG antibod y was o bta ined fro m O rtho-
Munne (U .S.A .) . 
B riefl y, 5 X 105 ce lls were pcl.le ted thro ug h 5 m l o f co ld phos-
p h a t e-bu ffered sa line (PBS) fo r 5 min at 200 g. The pelle t w as 
th en res uspend ed in 100 ,ul o f PBS, mi xed w ith 10 ,ul o f non-
conju gated antibod y reagents O KT 4 o r O KT8,. and in cubated 
fo r 45 min at 4°C, fo llo w ed b y was hmg tw ice 111 co ld PBS at 
4°C. T he cell pell et was resuspended in 100 ,ul of o ptimal di lu ti on 
of flu o rescein-conju ga ted goat antim o use lgG and in cubated in 
th e d ark for 30 min at 4°C. The pelle t was res uspended in a sm all 
volume o f 50'Yo g lycero l in PBS and wet m o unts prepared. The 
per centage o f 200 cells disp lay in g surface m embrane flu o rescence 
was d etected using a flu o rescence mi crosco pe (O pton). 
H. ES ULTS AN D DI SC U SS IO N 
We confirmed o ur pre vio us resu lts [8) of lowered ang iogeni c 
cap a bility o f peripheral blood MN C fro m patients w ith SSe, ir-
resp ective of the type of th e disease, as compared With th at of 
contro l MN C (Table II). The present stud y revealed that the 
lowered an giogenic ca pability was fo und on ly w hen to tal MNC 
were tested . H o weve r, when peripheral blood MNC were sep-
a ra te d in to m o nocy te- enri ched and m onocy te-depleted subsets, 
non e ex hibi ted low ered an giogeni c ca pabi lity. M o reove r, we 
showed a signifi cantl y hi g her c:~p a bility o f th e m o nocy te-enri ched 
subset fro m patients w ith SSe as compared w ith th e correspond-
ing s ubse t fro m health y indi viduals and _with th e m o nocyte-de-
ple te d fr acti o n fro m the patients._ Sm ce this subset m ost ly con ~ 1 s ts 
of m o nocy tes, 1t co uld be antiCipated that these cells arc m aml y 
res p o nsible fo r the observed ang iogenes is enh ancement. How-
ever , we ca nn o t exclude the possibility that this m onocy te- stim -
u la te d ang iogenesis is m edia ted b y so m e o ther cell type present 
in t hi s frac tio n. 
It is known th at m o nocy te/m acro phage cells arc ca pable of 
indu cin g ang iogenesi s [1 9 j, es peciall y when act iva ted in v ivo [20[. 
T h e increased angiogenic ca p :~ bi li t y o f m onocy tcs fro m pati ents 
wi th SSe mig ht refl ect in vi vo preacti va tion of th ese cells durin g 
th e a u toimmune reactio n [5-7), o r increased capability to beco m e 
activa ted durin g in vitro separatio n . The poss ibility o f in vivo 
activa ti o n could not be rej ected , since it was recent ly shown that 
mon ocy tes fro m patients w ith SSe arc ca pable o f spontaneo us 
gen era tio n of interleukin-_1 [21J. . . . 
T h e increased ang10gem c ca pab1ht y o fm o nocy tcs fro m patients 
w ith SSe is intri g uin g in view o f th e lo wered c:~ pa bilit y o f to tal 
MNC fracti o n . It is poss ible th at inhibito ry interacti o ns occur 
amon g different MN C subsets, as was show n fo r vario us T-ccll 
sub p o pubtio ns iso lated o n the basis o f the affinit y fo r sheep red 
blood cell s [17 [, as w ell as fo r interleukin-1 produ cti on in patients 
with SSe, w hi ch m ay be reg ulated b y inhibito ry facto rs fro m 
M N C and /or by cell interac tio ns [22]. Thus, t h<.: apparent dis-
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Table IlL T -Lymphocyte Antigeni c D etermin ants on 
T o tal MN C and o n N o nadherent Cell s in Pa tients wi th SSe 
Total MN C Monocyte-Depleted 
O KT4 O KT8 O KT4 OKT8 
SSe 50.4 ± 3.4 1 38.3 ± 5.48 49.5 ± 2.30 34.7 ± 4.74'' 
(n 10) (n 10) (n = 10) (n = 10) 
Control 51. 6 ± 2. 18 31.5 ± 2.57 52.2 ± 2.64 21. 5 ± 1. 23 
(n = 10) (n = 10) (n = 8) (n = 8) 
Rcsulrs exp ressed :~s :1 mean pc rcen ta~c ::!:: SE ofOKT4- or OKTS-posi ti v<" n· ll s. 
T he number of in d i v id u :~ l s tested is g iven in pa rentheses. 
"Difrcrc nt fro m co nt ro l at p < 0.05. 
crep:lll cy between redu ced angiogeni c capa bility o f to tal M N C 
and increased po tentia l of their adh erent frac tio n mig ht be ex-
pl ained by the existen ce o f so m e suppresso r cell s actin g o n the 
m onocy tes, so that th ey ca nno t m o bili ze endothelial ce lls w ithin 
the microvascul ature. 
T o in ves ti ga te this, we exa min ed the distribu tion of T-l y m-
phocyte subset-specific antigens O KT4 (helper-indu cer) and O KT8 
(cy totox ic- suppressor) in tota l MN C and in m onocy te- de pleted 
MN C subsets (T able Ill ). We fo und an increased pc rccnrage of 
O KT8- positi ve cells in the m o nocy te-depleted fract io n of MN C 
fro m patients with SSe, as compared with the cont ro l, and no 
difference in to ta l MN C po pulati ons. T his indi cates so me q ual-
ita ti ve differences am ong OKT8-positive subsets exp ressed by an 
increased percentage o f nonadh erent O KT8-positive cells in pa-
ti ents w ith SSe. 
The impo rtance of interacti o ns o f d iffe ren t MN C subpop ul a-
ti ons fo r the pathogenesis o f SSe requires furth er stud ies . 
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